Treatment of the paraphilic disorders: A review of the role of the selective serotonin reuptake inhibitors

Sexual Abuse: Journal of Research and Treatment

Volumn 9, Issue 4, 1997, Pages 349-360

  Greenberg, David M ^a,b   Bradford, John M W ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b ROYAL OTTAWA HOSPITAL   (Canada)

Author keywords

Paraphilic disorders; Selective serotonin reuptake inhibitors; Serotonin; Sexual offenders

Indexed keywords

EID: 0000371694     PISSN: 10790632     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02674858     Document Type: Review

References (60)

1. Ambrosi, B., Travaglini, P., Gaggini, N., Moriondo, P., Elli, R., Bara, R., & Faglia, G. (1979). Effects of serotonin antagonists in sexually impotent men. Andrologia, 11, 475-477.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association.
3. Bartholomew, A. A. (1968). A long-acting phenothiazine as a possible agent to control deviant sexual behavior. American Journal of Psychiatry, 124, 917-923.
4. Becker, J. V. (1995). The President's Message. The Forum. Association for the Treatment of Sexual Abusers (ATSA), 7(2), 1-2.
5. Berlin, F. S. (1989). The paraphilias and depo-Provera: Some medical, ethical and legal considerations. Bulletin of the American Academy of Psychiatry and the Law, 17, 233-239.
6. Berlin, F., & Meineke, C. S. (1981). Treatment of sex offenders with anti-androgenic medication; Conceptualization, review of treatment modalities and preliminary findings. American Journal of Psychiatry, 138, 601-607.
7. Bianchi, M. D. (1990). Fluoxetine treatment of exhibitionism [Letter to the Editor]. American Journal of Psychiatry, 147, 1089-1090.
8. Bradford, J. (1988). Organic treatment for the male sex offender. Annals of the New York Academy of Sciences, 528, 193-201.
9. Bradford, J., & Pawlak, A. (1993). Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Archives of Sexual Behavior, 22, 383-401.
10. Bradford, J., Greenberg, D. M., Gojer, J. J., Martindale, J. J., & Goldberg, M. (1995). Sertraline in the treatment of pedophilia: An open labelled study. Paper presented at the annual American Psychiatric Association Congress, Miami, FL, May.
11. Coleman, E., Cesnick, J., Moore, A. & Dwyer, S. N. (1992). An exploratory study of the role of psychotropic medications in the treatment of sex offenders. Journal of Offender Rehabilitation, 18, 75-88.
12. Cooper, A. J., Sardhu, S., Losztyn, S., & Cornovsky, Z. (1992). A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Canadian Journal of Psychiatry, 37, 687-693.
13. Davies, T. S. (1970). Cyproterone acetate in sexual misbehavior. Medical Science and the Law, 10, 237-242.
14. Dickey, R. (1992). The management of a case of treatment resistant paraphilia with a long-acting LHRH agonist. Canadian Journal of Psychiatry, 37, 567-569.
15. Emmanuel, M. P., Lydiard, R. B., & Ballenger, J. C. (1991). Fluoxetine treatment of voyeurism [Letter to the Editor]. American Journal of Psychiatry, 148, 950.
16. Faller, K. C. (1989). Why sexual abuse? An exploration of the intergenerational hypothesis. Child Abuse and Neglect, 13, 543-548.
17. Foote, R. M. (1944). Diethylstilbestrol in the management of the psychological state of males. Journal of Nervous and Mental Disease, 99, 928-935.
18. Fuller, R. W. (1986). Pharmacologic modification of serotonergic function: Drugs for the study and treatment of psychiatric and other disorders. Journal of Clinical Psychiatry, 47, 4-8.
19. Gagné, P. (1981). Treatment of sex offenders with medroxyprogesterone acetate. American Journal of Psychiatry, 160, 127-137.
20. Gelinas, D. J. (1983). The persisting negative effects of incest. Postgraduate Psychiatry, 46, 312-332.
21. Gessa, G. L., & Tagliamonte, A. (1975). Role of brain serotonin and dopamine in male sexual behavior. In M. Sandler & G. L. Gessa (Eds.), Sexual behavior: Pharmacology and biochemistry (pp. 117-128). New York: Raven Press.
22. Gitlin, M. J. (1994). Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55, 406-413.
23. Gorzalka, B. B., Mendelson, S. D., & Watson, N. V. (1990). Serotonin receptor subtypes and sexual behavior. Annals of the New York Academy of Sciences, 600, 435-493.
24. Gottesman, H. G., & Schubert, D. S. (1993). Low dose oral medroxyprogesterone acetate in the management of the paraphilias. Journal of Clinical Psychiatry, 54, 182-188.
25. Greenberg, D. M., Bradford, J. M., Curry, S., & O'Rouche, A. (1996a). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Bulletin of the American Academy of Psychiatry and the Law, 24, 525-532.
26. Greenberg, D. M., Bradford, J. M., Curry, S., & O'Rouche, A. (1996b). A controlled study of the treatment of paraphilia disorders with selective serotonin reuptake inhibitors. Annual meeting of the Canadian Academy of Psychiatry and the Law, Tremblay, Quebec.
27. Guy, W. (1976). ECDEU assessment manual for psychopharmacology, review (pp. 76-338). Rockville, MD: National Institute of Mental Health, United States Department of Health, Education, and Welfare Publication ADM.
28. Harrison, W. M., Stewart, J., Ehrhardt, A., Rabkin, J., McGrath, P., Liedowitz, M., & Quitkin, F. N. (1985). A controlled study of the effects of antidepressants on sexual functioning. Psychopharmacological Bulletin, 21, 85-88.
29. Harrison, W. M., Rabkin, J. G., Ehrhardt, A. A., Stewart, J. W., McGrath, P. J., Ross, D., Quitkin, F. N. (1986). Effects of antidepressant medication on sexual functioning: A controlled study. Journal of Clinical Psychopharmacology, 6, 144-149.
30. Heim, N., & Hursch, C. J. (1979). Castration for sexual offenders: Treatment of punishment? A review and critique of recent European literature. Archives of Sexual Behavior, 8, 281-304.
31. Hucker, S. J., Langevin, R., & Bain, J. (1988). A double-blind trial of Provera for pedophiles. Annals of Sex Research, 1, 227-242.
32. Hyyppa, M. T., Flack, S., Aukia, H., & Rinne, U. K. (1975). Neuroendocrine regulation of gonadotropin secretion and sexual motivation after L-tryptophan administration in man. In M. Sandler & G. L. Gessa (Eds.), Sexual behavior: Psychopharmacology and biochemistry (pp. 307-314). New York: Raven Press.
33. Kafka, M. P. (1991a). Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 52, 60-65.
34. Kafka, M. P. (1991b). Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. British Journal of Psychiatry, 158, 844-847.
35. Kafka, M. P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: An open trial. Annals of Clinical Psychiatry, 6, 189-195.
36. Kafka, M. P. (1996). Hypersexual desire: Clinical implications for men with paraphilias and paraphilia-related disorders. The Forum, Association of the Treatment of Sexual Abusers, 8, 4-5.
37. Kafka, M. P., & Prentky, R. (1992). Fluoxetine treatment of non paraphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 53, 351-358.
38. Kaplan, H. S. (1995). The sexual desire disorders: Dysfunctional regulation of sexual motivation (pp. 15-18). New York: Brunner.
39. Laschet, U., & Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men. Journal of Steroid Biochemistry, 6, 821-826.
40. Lorefice, L. S. (19910. Fluoxetine treatment of a fetish [Letter to the Editor]. Journal of Clinical Psychiatry, 52, 41.
41. Mendelson, S. D., & Gorzalka, B. B. (1990). Sex differences in the effects of 1-(m-trifluoromethylphenyl)piperazine and 1-(m-chlorophenyl) piperazine on copulatory behavior in the rat. Neuropharmacology, 29, 783-786.
42. Meston, C. M., & Gorzalka, B. B. (1992). Psychoactive drugs and human sexual behavior: The role of serotonergic activity. Journal of Psychoactive Drugs, 24, 1-40.
43. Moser, C. (1992). Lust, lack of desire, and paraphilias: some thoughts and possible connections. Journal of Sex & Marital Therapy, 18, 65-69.
44. Murphy, D. L., Mueller, E. A., Garrick, N. A., & Aulakh, C. S. (1986). Use of serotonergic agents in the clinical assessment of central serotonin function. Journal of Clinical Psychiatry, 47 (Suppl.), 9-15.
45. Nagayama-Hall, G. C. (1996). Sexual offender recidivism revisited: A meta-analysis of recent treatment studies. Journal of Consulting and Clinical Psychology (in press).
46. Nininger, J. E. (1978). Inhibition of ejaculation by amitriptyline. American Journal of Psychiatry, 135, 750-751.
47. Nurnberg, H. G., & Levine, P. E. (1987). Spontaneous remission of MAOI-induced anorgasmia. American Journal of Psychiatry, 144, 805-807.
48. Paul, S. M., Janowsky, A., & Skolinck, P. (1985). Monoaminergic neurotransmitters and antidepressant drugs. In R. E. Hales & A. J. Francis (Eds.), Psychiatry update: American Psychiatric Association annual review, Vol. 4 (pp. 37-48). Washington, DC: American Psychiatric Press.
49. Perilstein, R. D., Lipper, S., & Friedman, L. J. (1991). Three cases of paraphilias responsive to fluoxetine treatment. Journal of Clinical Psychiatry, 52, 169-170.
50. Rodriguez, M., Castro, R., Hernandez, G., & Mas, M. (1984). Different roles of catecholaminergic and serotoninergic neurons of the medial forebrain bundle on male rat sexual behavior. Physiology and Behavior, 33, 5-11.
51. Seagraves, R. T. (1989). Effects of psychotropic drugs on human erection and ejaculation. Archives of General Psychiatry, 46, 275-284.
52. Sjoertsm, A., Lovenberg, W., Engleman, K., Carpenter, W. T., Wyatt, R. J., & Gessa, G. L. (1970). Serotonin now: Clinical implications of inhibiting its synthesis with paraclorophenylaline. Annals of Internal Medicine, 73, 607-629.
53. Sovner, R. (1984). Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. Journal of Clinical Psychopharmacology, 4, 169.
54. Steele, T. E., & Howell, E. F. (1986). Cyproheptadine for imipramine-induced anorgasmia. Journal of Clinical Psychopharmacology, 6, 326-327.
55. Stein, D. J., Hollander, E., Anthony, D. T., Schneier, F. R., Fallon, B. A., Liebowitz, R. W., & Klein, D. F. (1992). Serotonergic medications for sexual obsessions, sexual addictions and paraphilias. Journal of Clinical Psychiatry, 53, 267-271.
56. Thibaut, F., Cordier, B., & Kuhn, J. M. (1993). Effect of long-lasting gonadotrophin hormone-releasing agonist in sex cases of severe male paraphilia. Acta Psychiatrica Scandinavica, 87, 445-450.
57. Tucker, T. C., & File, S. E. (1983). Serotonin and sexual behavior. In D. Wheatley (Ed.), Psychopharmacology and sexual disorders (pp. 22-49). New York: Oxford University Press.
58. Whittaker, L. H. (1959). Estrogens and the psychosexual disorders. Medical Journal of Australia, 2, 547-549.
59. Zajecka, J., Fawcett, J., Schaff, M., Jefferess, H., & Guy, C. (1991). The role of serotonin in sexual dysfunction: Fluoxetine-associated orgasm dysfunction. Journal of Clinical Psychiatry, 52, 66-68.
60. Zohar, J., Kaplan, Z., & Benjamin, J. (1994). Compulsive exhibitionism successfully treated with fluvoxamine: A controlled case study. Journal of Clinical Psychiatry, 55, 86-88.